Table 1 Specifications of the cases reported in the study
Sex | Age | The onset of hip symptoms (days from COVID infection) | Pre-op ESR (mm/h) | Pre-op CRP (mg/l) | Hip involved | Culture | Medication used in addition to corticosteroid | Dose of corticosteroids (mg of prednisolone) | AB used | Pre-op VAS score | Post-op VAS score | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 | M | 34 | 56 | 110 | 140 | Left | Negative | Remdesivir | 1384.5 | Imipenem + Vancomycin | 10 | 4 |
Case 2 | F | 14 | 43 | 64 | 90 | Bilateral | Non-typhoid salmonella | Remdesivir | 2009.5 | Ceftriaxone | 9 | 1 |
Case 3 | F | 52 | 30 | 40 | 69 | Right | Negative | Azithromycin | 2010 | imipenem + Vancomycin | 9 | 3 |
Case 4 | F | 54 | 29 | 59 | 65 | Bilateral | Serratia marcescens | Azithromycin, hydroxychloroquine | 1697 | imipenem + Vancomycin | 10 | 4 |
Case 5 | M | 38 | 50 | 112 | 145 | Bilateral | Coagulase negative staphylococci | Remdesivir, Actemra | 1375 | Targocid | 9 | 2 |